
The Epidermal Growth Factor Receptor-L861Q Mutation Increases Kinase Activity without Leading to Enhanced Sensitivity Toward Epidermal Growth Factor Receptor Kinase Inhibitors
Keywords: EGFR; Kinase activity; Gefitinib; Erlotinib; Drug sensitivity